Oxford BioMedica PLC (OXB) — Long-term Investment Intensity

Latest as of December 2018: 9.8%

Oxford BioMedica PLC (OXB) has a Long-term Investment Intensity of 9.8% as of December 2018. Long-term investments of GBX10.97 Million represent 9.8% of total assets of GBX112.40 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Oxford BioMedica PLC (OXB) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

9.8%
LT Investments / Total Assets

Long-term Investments

GBX10.97 Million
GBX

Total Assets

GBX112.40 Million
GBX

Country

UK
LSE

Oxford BioMedica PLC Long-term Investment Intensity (2016–2018)

This chart shows how Oxford BioMedica PLC's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of December 2018, the intensity stands at 9.8%, reflecting long-term investments of GBX10.97 Million against total assets of GBX112.40 Million GBX. For the complete balance sheet picture, see OXB total asset value.

Annual Long-term Investment Intensity for Oxford BioMedica PLC (2016–2018)

The table below presents the year-by-year Long-term Investment Intensity for Oxford BioMedica PLC from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read OXB liabilities breakdown for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (GBX) Total Assets Change (pp)
2018 9.8% GBX10.97 Million GBX112.40 Million ▲ +5.2 pp
2017 4.5% GBX2.95 Million GBX65.40 Million ▲ +3.4 pp
2016 1.2% GBX657.00K GBX56.94 Million
pp = percentage points